High‐frequency stimulation of the subthalamic nucleus enhances striatal dopamine release and metabolism in rats

High‐frequency stimulation of the subthalamic nucleus is believed to exert its main effects via the basal ganglia output structures. Previously, we have shown a concomitant increase in striatal dopamine (DA) metabolites in normal and 6‐hydroxydopamine‐lesioned rats. The present study was designed to determine whether this increase in striatal DA metabolites reflects enhanced intraneuronal DA turnover or, alternatively, is due to increased DA release with subsequent rapid and efficient reuptake and/or metabolism. Thus, high‐frequency stimulation of the subthalamic nucleus was performed in normal rats after inhibition of DA reuptake, metabolism or DA depletion. Extracellular levels of striatal DA and its metabolites were assessed using microdialysis. Our data suggest that subthalamic high‐frequency stimulation increases striatal DA release and activates independent striatal DA metabolism. Since such changes could be triggered by modification of either the activity or the gene expression of the rate‐limiting enzyme tyrosine hydroxylase, an activity assay and RT‐PCR of striatal and nigral samples were performed. Subthalamic stimulation increased striatal tyrosine hydroxylase activity without affecting gene expression. We, therefore, conclude that the application of subthalamic high‐frequency stimulation could partially compensate for the DA deficit by inducing increased striatal DA release and metabolism.

[1]  Y. Miyashita,et al.  Quantification of neurotrophin-3 mRNA in the rat hippocampal subregions using the RT-PCR-based coamplification method. , 1999, Brain research. Brain research protocols.

[2]  A Benazzouz,et al.  Stimulation of subthalamic nucleus alleviates tremor in Parkinson's disease , 1997, The Lancet.

[3]  R. Duvoisin,et al.  Treatment of parkinsonism with levodopa. , 1969, Archives of neurology.

[4]  U. Ungerstedt,et al.  In Vivo Measurement of Dopamine and Its Metabolites by Intracerebral Dialysis: Changes After d‐Amphetamine , 1983, Journal of neurochemistry.

[5]  R. Roth,et al.  Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid. , 1976, European journal of pharmacology.

[6]  J. Bowyer,et al.  Long-term effects of amphetamine neurotoxicity on tyrosine hydroxylase mRNA and protein in aged rats. , 1998, The Journal of pharmacology and experimental therapeutics.

[7]  P. Waldmeier,et al.  Comparison of short and long-lasting effects of pargyline on cerebral dopamine metabolism , 1976, Naunyn-Schmiedeberg's Archives of Pharmacology.

[8]  D. Palm,et al.  Rates of recovery of irreversibly inhibited monoamine oxidases: A measure of enzyme protein turnover , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[9]  J. B. Justice,et al.  Modeling the dopaminergic nerve terminal , 1988, Journal of Neuroscience Methods.

[10]  R. Roth,et al.  Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo. , 1986, The Journal of pharmacology and experimental therapeutics.

[11]  A. Kupsch,et al.  High frequency stimulation of the subthalamic nucleus influences striatal dopaminergic metabolism in the naive rat , 2000 .

[12]  K. Krnjević,et al.  Intracellular actions of monoamine transmitters. , 1978, Canadian journal of physiology and pharmacology.

[13]  Rudolf Morgenstern,et al.  Deep brain stimulation of subthalamic neurons increases striatal dopamine metabolism and induces contralateral circling in freely moving 6-hydroxydopamine-lesioned rats , 2002, Neuroscience Letters.

[14]  M. Matsunaga,et al.  Reserpine Pretreatment Prevents Increases in Extracellular Striatal Dopamine Following L‐DOPA Administration in Rats with Nigrostriatal Denervation , 2000, Journal of neurochemistry.

[15]  G. Gerhardt,et al.  Microdialysis studies of basal levels and stimulus-evoked overflow of dopamine and metabolites in the striatum of young and aged Fischer 344 rats , 1999, Brain Research.

[16]  J. Richards,et al.  In vivo dialysis measurements of dopamine and DOPAC in rats trained to turn on a circular treadmill , 1990, Pharmacology Biochemistry and Behavior.

[17]  E. Krebs,et al.  ERK1 and ERK2, two microtubule-associated protein 2 kinases, mediate the phosphorylation of tyrosine hydroxylase at serine-31 in situ. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[18]  F. Windels,et al.  High Frequency Stimulation of the Subthalamic Nucleus Increases the Extracellular Contents of Striatal Dopamine in Normal and Partially Dopaminergic Denervated Rats , 2001, Journal of neuropathology and experimental neurology.

[19]  A. Benabid,et al.  Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson's disease , 1997, The Lancet.

[20]  D. Segal,et al.  Tyrosine hydroxylase activity: Regional and subcellular distribution in brain , 1974 .

[21]  M. Hallett,et al.  Mechanism of action of deep brain stimulation. , 2000, Neurology.

[22]  J. D. Parkes,et al.  Fluctuations of disability in Parkinson's disease – clinical aspects , 1981 .

[23]  K. Fuxe,et al.  SITE OF ACTION OF RESERPINE. , 2009, Acta pharmacologica et toxicologica.

[24]  N. Ozaki,et al.  Differential effect of self-stimulation on dopamine release and metabolism in the rat medial frontal cortex, nucleus accumbens and striatum studied by in vivo microdialysis , 1992, Brain Research.

[25]  G. Arbuthnott,et al.  Brain microdialysis studies on the control of dopamine release and metabolism in vivo , 1990, Journal of Neuroscience Methods.

[26]  D. Segal,et al.  Reserpine enhances amphetamine stereotypies without increasing amphetamine-induced changes in striatal dialysate dopamine , 1989, Brain Research.

[27]  A. Medvedev,et al.  The stimulating effects of ethanol consumption on synthesis of rat brain monoamine oxidases and their sensitivity to the irreversible inhibitor, pargyline , 2000, Neuroscience Letters.

[28]  G. Arbuthnott,et al.  Dopamine release and metabolism in the rat striatum: an analysis by 'in vivo' brain microdialysis. , 1990, Pharmacology & therapeutics.

[29]  K. Vrana,et al.  Intricate Regulation of Tyrosine Hydroxylase Activity and Gene Expression , 1996, Journal of neurochemistry.

[30]  R. Lindberg,et al.  Metabolism of nomifensine after oral and intravenous administration , 1986, Clinical pharmacology and therapeutics.

[31]  N. Wetzel SURGICAL TREATMENT OF PARKINSON'S DISEASE. , 1963, Chicago medicine.

[32]  O. J. Broch,et al.  On the mode of action of reserpine on dopamine metabolism in the rat striatum. , 1971, European journal of pharmacology.

[33]  A. Benabid,et al.  Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. , 1998, The New England journal of medicine.

[34]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[35]  L. Swanson The Rat Brain in Stereotaxic Coordinates, George Paxinos, Charles Watson (Eds.). Academic Press, San Diego, CA (1982), vii + 153, $35.00, ISBN: 0 125 47620 5 , 1984 .

[36]  G. Arbuthnott,et al.  Amphetamine‐Induced Dopamine Release in the Rat Striatum: An In Vivo Microdialysis Study , 1988, Journal of neurochemistry.

[37]  A. Kupsch,et al.  Striatal dopaminergic metabolism is increased by deep brain stimulation of the subthalamic nucleus in 6-hydroxydopamine lesioned rats , 2001, Neuroscience Letters.

[38]  T. Hökfelt,et al.  Dopamine D2 receptors regulate tyrosine hydroxylase activity and phosphorylation at Ser40 in rat striatum , 2001, The European journal of neuroscience.

[39]  A. Benabid,et al.  Long‐Term Electrical Inhibition of Deep Brain Targets in Movement Disorders , 2008, Movement disorders : official journal of the Movement Disorder Society.

[40]  O. Hornykiewicz,et al.  Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. , 1960, Parkinsonism & related disorders.

[41]  T. Lee,et al.  A microdialysis study on striatal dopamine, 5‐HT and metabolites in conscious rats after various treatments: evidence for extravesicular release of dopamine , 1993, Neuroreport.

[42]  R. Roth,et al.  Dopamine Synthesis, Uptake, Metabolism, and Receptors: Relevance to Gene Therapy of Parkinson's Disease , 1997, Experimental Neurology.

[43]  Anders Björklund,et al.  Regional differences in the regulation of dopamine and noradrenaline release in medial frontal cortex, nucleus accumbens and caudate-putamen: a microdialysis study in the rat , 1992, Brain Research.

[44]  T. Kato,et al.  Highly sensitive assay for tyrosine hydroxylase activity by high-performance liquid chromatography. , 1979, Journal of chromatography.

[45]  G. Arbuthnott,et al.  Effects of Selective Monoamine Oxidase Inhibitors on the In Vivo Release and Metabolism of Dopamine in the Rat Striatum , 1990, Journal of neurochemistry.

[46]  G. Chiara,et al.  Stimulation of dopamine transmission in the dorsal caudate nucleus by pargyline as demonstrated by dopamine and acetylcholine microdialysis and Fos immunohistochemistry , 1993, Neuroscience.

[47]  G. Di Chiara,et al.  Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[48]  H. Ehringer,et al.  Verteilung Von Noradrenalin Und Dopamin (3-Hydroxytyramin) Im Gehirn Des Menschen Und Ihr Verhalten Bei Erkrankungen Des Extrapyramidalen Systems , 2005, Klinische Wochenschrift.

[49]  M. Naoi,et al.  Simple assay procedure for tyrosine hydroxylase activity by high-performance liquid chromatography employing coulometric detection with minimal sample preparation. , 1988, Journal of chromatography.

[50]  M. Garcia-Munoz,et al.  Electrophysiological analysis of dopamine cells from the substantia nigra pars compacta of circling rats , 2004, Experimental Brain Research.

[51]  U. Ungerstedt,et al.  In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. , 1988, European journal of pharmacology.

[52]  F. Bergquist,et al.  3‐Methoxytyramine Formation Following Monoamine Oxidase Inhibition Is a Poor Index of Dendritic Dopamine Release in the Substantia Nigra , 1997, Journal of neurochemistry.